Menu
Back to User profile » Dr Yanqiu Wu
Papers published by Dr Yanqiu Wu:
Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis
Peng J, Wang M, Wu Y, Shen Y, Chen L
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2567-2575
Published Date: 12 October 2022
Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation
Wu Y, Qin J, He J, Shen Y, Wang H, Li Y, Zeng Q, Dong J, An Y, Xiong S, Feng M, Wen F
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:397-407
Published Date: 25 February 2020
Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD
Li D, Wu Y, Guo S, Qin J, Feng M, An Y, Zhang J, Li Y, Xiong S, Zhou H, Zeng Q, Chen L, Wen F
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1933-1941
Published Date: 28 August 2019
Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease
Wang H, Yang T, Li D, Wu Y, Zhang X, Pang C, Zhang J, Ying B, Wang T, Wen F
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2369-2376
Published Date: 26 September 2016